Hypofractionated Radiotherapy for Localized Prostate Cancer (With CyberKnife or With IMRT)
Completed · Phase 2
Conditions studied: Prostatic Neoplasms
In brief
To demonstrate that a hypo-fractionated course of radiotherapy (ie. an accelerated radiotherapy course where fewer but larger doses of radiotherapy are given) is both safe and effective in the treatment of low-risk localized prostate cancer.
Key facts
- Study ID
- NCT00855647
- Run by
- Stanford University
- People needed
- 99999
- Starts
- 2003-08-01
- Expected to finish
- 2009-07-01
- Last updated by the study team
- 2010-06-03
Who can join
Age: 18 and older. Sex: male. Healthy volunteers: not accepted.
Where it is running
- Stanford University School of Medicine — Stanford, California, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.